Considerations in the physician's decision to prescribe benzodiazepines to patients with addiction

Psychiatric Annals

Volumn 28, Issue 3, 1998, Pages 160-165

  Johnson, Brian ^a,b   Longo, Lance P ^c,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Bournewood Hospital   (United States)

^c AURORA SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032400428     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19980301-12     Document Type: Article

References (36)

1. Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. NEJM 1993;328:1398-1405.
2. Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry. 1988;145:1501-1506.
3. Adinoff B. Long-term therapy with benzodiazepines despite alcohol dependence disorder, seven case reports. Am J Addictions. 1992;1:288-293.
4. Marshall JR. The diagnosis and treatment of social phobia and alcohol abuse. Bull Menninger Clin. 1994;58:A58-66.
5. Rosenbaum JF, Pollock RA. The psychopharmacology of social phobia and comorbid disorders. Bull Menninger Clin. 1994;58:A67-83.
6. DuPont RL. Anxiety and addiction: a clinical perspective on comorbidity. Bull Meninger Clin. 1995;59:A53-A72.
7. Smith DE, Wesson DR. Benzodiazepine dependency syndromes. J Psychoactive Drug. 1983;15:85-95.
8. Smith DE, Wesson DR. Benzodiazepines and other sedative-hypnotics. In: Galanter M, Kleber HD, eds. The American Psychiatric Press Textbook of Substance Abuse Treatment. Washington DC: American Psychiatric Press; 1994:179-190.
9. Gold MS, Miller NS. Seeking drugs/alcohol and avoiding withdrawal: the neuroanatomy of drive and withdrawal. Psychiatric Annals. 1992;22:430-435.
10. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSMIIR psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.
11. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry. 1990;147:685-695.
12. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry. 1994;151:1723-1734.
13. Kadden RM, Kranzler HR, Rounsaville BJ. Validity of the distinction between "substance-induced" and "independent" depression and anxiety disorders. Am J Addiction. 1995;4:107-117.
14. Salzman C. The APA task force report on benzodiazepine dependence, toxicity and abuse. Am J Psychiatry. 1991;148:151-152.
15. Mueller TI, Goldenberg IM, Gordon AL, Keller MB, Warshaw MG. Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism. J Clin Psychiatry. 57:83-89.
16. Rickels K, Case WG, Schweizer E, Garcia-Espana F, Friedman R. Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am J Psychiatry. 1991;148:757-761.
17. Busto U, Sellers EM. Pharmacologic aspects of benzodiazepine tolerance and dependence. J Subst Abuse Treat. 1991;8:29-33.
18. Winokur A, Rickels K, Greenblatt DJ, Snyder PJ, Schatz NJ. Withdrawal reaction from long-term low-dosage administration of diazepam. Arch Gen Psychiatry. 1980;37:101-105.
19. Noyes R, Garvey MJ, Cook BL, Perry PJ. Benzodiazepine withdrawal: a review of the evidence. J Clin Psychiatry. 1988;49:382-389.
20. Ashton H. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat. 1991;8:19-28.
21. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet. 1983;1:1402-1406.
22. Miller NS, Mirin SM. Multiple drug use in alcoholics: practical and theoretical implications. Psychiatric Annals. 1989;19:248-255.
23. Liskow B, Samuelson S, Powell B, Campbell J. Co-occurrence of psychiatric disorders and alcoholism in untreated alcoholic patients in a VA medical walk-in (triage) clinic population. Am J Addictions. 1995;4:150-155.
24. Van Amerigen M, Mancini C, Streiner DL. Fluoxetine efficacy in social phobia. J Clin Psychiatry. 1993;54:27-32.
25. Pigott TA, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder, behavioral and biological results. Arch Gen Psychiatry. 1990;47:926-32.
26. Davidson J. Drug therapy of posttraumatic stress disorder. Br J Psychiatry. 1992;160:309-314.
27. Ansseau M, DeRoeck J. Trazodone in benzodiazepine dependence. J Clin Psychiatry. 1993;54:189-191.
28. Rickets K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder, a placebo-controlled comparison of imipramine, trazedone and diazepam. Arch Gen Psychiatr. 1993;50:884-895.
29. Coleman JH, Klerman GL, Ayuso JL, et. al. Drug treatment of panic disorder, comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry. 1992;160: 191-202.
30. Ciraulo D. Abuse potential of benzodiazepines. Bull NY Acad Med. 1985;61:728-741.
31. Juergens S. Alprazolam and diazepam: addiction potential. J Subst Abuse Treat. 1991;8:43-51.
32. Top 200 drugs of 1995. In: American Druggist. New York: Hearst Business Publishers; 1996:18-26.
33. Smith DE, Seymour RB. Benzodiazepines. In: Comprehensive Handbook of Drug and Alcohol Addiction. Ed. Miller NS. New York: Marcel Dekker. 1991:405-26.
34. Trudeau DL. Clonazepam prescribing patterns and abuse by methadone patients in a medical center setting. J Addictive Dis. 1994;13:99-107.
35. Miller NS, Gold MS. Introduction - benzodiazepines: a major problem. J Subst Abuse Treat. 1991;8:3-7.
36. Zinberg NE. Drug, Set and Setting: The Basis for Controlled Intoxicant Use. New Haven: Yale University Press; 1984.